Paper Details

  1. Home
  2. Paper Details

Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.

Author: EzekowitzMichael D, JamiesonDara G, ParekhAmit

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review compares the efficacy of various antiplatelet agents for preventing recurrent strokes, including aspirin, ticlopidine, clopidogrel, extended-release dipyridamole, and triflusal.
Paper Details　
Original Abstract of the Article :
Patients experiencing stroke or transient ischemic attack (TIA) are at high risk for recurrent (secondary) strokes, which comprise 29% of all strokes in the United States. Current recommendations for prevention of secondary stroke from the American College of Chest Physicians (ACCP) call for the bro...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/107424840501000302

データ提供：米国国立医学図書館（NLM）

Antiplatelet Therapy: Navigating the Desert of Stroke Prevention

Stroke, a devastating neurological event, can have long-lasting effects on an individual's life. This review article explored the role of antiplatelet therapy in preventing secondary stroke, focusing on the need for direct comparisons between different antiplatelet agents. Like a camel navigating a vast and complex desert, researchers are constantly seeking the most effective strategies for stroke prevention. The review examined the results of various clinical trials involving different antiplatelet agents, comparing their efficacy and safety profiles.

Finding the Right Path for Stroke Prevention

The review highlights the importance of carefully evaluating the efficacy and safety of different antiplatelet agents to identify the most effective strategies for stroke prevention. The need for direct comparisons between agents is crucial for making informed decisions about treatment strategies and ensuring optimal patient outcomes.

Reducing Stroke Risk: A Collective Effort

The review underscores the importance of ongoing research and collaboration in the field of stroke prevention. By continuously evaluating the effectiveness of different therapies and seeking to improve existing treatments, medical professionals can work together to reduce the risk of stroke and improve the lives of those affected.

Dr.Camel's Conclusion

The desert of stroke prevention can be a vast and challenging landscape. This review article, like a well-charted map, guides researchers and clinicians in navigating the complex terrain of antiplatelet therapy. The need for direct comparisons between agents is crucial for finding the right path to reduce stroke risk and improve patient outcomes.

Date :
  1. Date Completed 2006-01-18
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

16211203

DOI: Digital Object Identifier

10.1177/107424840501000302

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.